Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.34% |
| 2 | Technology | 12.68% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Financials | 10.32% |
| 5 | Consumer Staples | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PBIP
1576
DELISTED
Prudential Bancorp, Inc.
PBIP
| $7.49M | 0.01% |
440,300
+2,510
| +0.6% | +$43.3K |
|
|
HTLF
1577
DELISTED
Heartland Financial USA, Inc.
HTLF
| $7.49M | 0.01% |
167,400
-41,200
| -20% | -$1.84M |
|
1578
Pebblebrook Hotel Trust
PEB
$2.06B
| $7.48M | 0.01% |
+268,900
| New | +$7.38M |
|
1579
Amphenol
APH
$206B
| $7.48M | 0.01% |
310,000
-2,043,600
| -87% | -$47.1M |
|
1580
First Northwest Bancorp
FNWB
$110M
| $7.46M | 0.01% |
430,905
+46,200
| +12% | +$752K |
|
|
PVLA
1581
Palvella Therapeutics
PVLA
$2.24B
| $7.46M | 0.01% |
27,353
+244
| +0.9% | +$94.5K |
|
1582
Laureate Education
LAUR
$5.16B
| $7.43M | 0.01% |
448,400
+61,224
| +16% | +$1.03M |
|
1583
e.l.f. Beauty
ELF
$5.42B
| $7.41M | 0.01% |
423,400
+114,700
| +37% | +$1.91M |
|
|
RTL
1584
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $7.39M | 0.01% |
529,733
+395,900
| +296% | +$4.82M |
|
|
DRRX
1585
DELISTED
DURECT Corp
DRRX
| $7.38M | 0.01% |
401,152
+80,363
| +25% | +$1.09M |
|
1586
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $7.38M | 0.01% |
84,600
-31,900
| -27% | -$2.77M |
|
1587
Enpro
NPO
$7.25B
| $7.37M | 0.01% |
107,300
+96,000
| +850% | +$6.23M |
|
1588
Vaalco Energy
EGY
$605M
| $7.36M | 0.01% |
3,626,355
+30,198
| +0.8% | +$53.2K |
|
1589
Regal Rexnord
RRX
$11.7B
| $7.35M | 0.01% |
100,900
-85,700
| -46% | -$6.47M |
|
|
ASRT
1590
DELISTED
Assertio
ASRT
| $7.33M | 0.01% |
95,438
+10,627
| +13% | +$1.38M |
|
1591
G. Willi-Food International
WILC
$395M
| $7.31M | 0.01% |
664,812
+300
| +0% | +$3.11K |
|
1592
Huntsman Corp
HUN
$1.8B
| $7.31M | 0.01% |
+314,300
| New | +$6.49M |
|
|
ACH
1593
Accendra Health
ACH
$77.7M
| $7.28M | 0.01% |
1,253,034
+426,484
| +52% | +$1.91M |
|
|
MRC
1594
DELISTED
MRC Global
MRC
| $7.28M | 0.01% |
+599,900
| New | +$8.47M |
|
|
OXFD
1595
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $7.28M | 0.01% |
437,576
-118,424
| -21% | -$1.64M |
|
|
SGI
1596
Somnigroup International
SGI
$13.9B
| $7.27M | 0.01% |
376,800
-256,800
| -41% | -$4.93M |
|
|
PLYM
1597
DELISTED
Plymouth Industrial REIT
PLYM
| $7.27M | 0.01% |
396,705
+183,500
| +86% | +$3.41M |
|
1598
Sociedad Química y Minera de Chile
SQM
$21.2B
| $7.25M | 0.01% |
+260,700
| New | +$7.19M |
|
|
SMMF
1599
DELISTED
Summit Financial Group, Inc.
SMMF
| $7.23M | 0.01% |
282,435
+7,081
| +3% | +$183K |
|
1600
Northrim BanCorp
NRIM
$605M
| $7.22M | 0.01% |
728,000
-16,400
| -2% | -$153K |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.